Cervix diseases

GFMER   Google   PubMed

Cervix

Adenocarcinoma in situ of the cervix

Cervical adenocarcinoma in situ
Endocervical adenocarcinoma in situ

Endocervical adenocarcinoma in situ (AIS)
IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16INK4a expression
Endocervical adenocarcinoma in situ (AIS)
Modern Pathology
Modern Pathology
NCI Bethesda System Web Atlas

Search with keyword(s) Wildcard = *
          


Print this page

Edited by Aldo Campana, July 16, 2014